Edition:
United States

Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

106.43USD
27 May 2016
Change (% chg)

$0.65 (+0.61%)
Prev Close
$105.78
Open
$106.29
Day's High
$106.74
Day's Low
$105.30
Volume
2,515,246
Avg. Vol
5,443,547
52-wk High
$140.72
52-wk Low
$92.98

MARIO ERNEST B

Institutional Holders

% Shares Owned: 80.35%
# of Holders: 1,634
Total Shares Held: 622,372,170
3 Mo. Net Change: -16,595,038
# New Positions: 106
# Closed Positions: 125
# Increased Positions: 636
# Reduced Positions: 712
# Net Buyers: -76

Officers & Directors

Name Age Since Current Position

Robert Hugin

61 2016 Executive Chairman of the Board

Jacqualyn Fouse

54 2016 President, Chief Operating Officer, Director

Mark Alles

56 2016 Chief Executive Officer, Director

Peter Kellogg

59 2014 Chief Financial Officer, Executive Vice President

Thomas Daniel

61 2016 Chairman - Celgene Research

Scott Smith

53 2014 Global President - Inflammation & Immunology

Rupert Vessey

2016 President - Research and Early Development

Robert Hershberg

50 2016 Chief Scientific Officer

Michael Casey

69 2007 Lead Independent Director

Michael Bonney

57 2015 Director

Julia Haller

2015 Director

Richard Barker

66 2012 Independent Director

Carrie Cox

58 2009 Independent Director

Michael Friedman

72 2011 Independent Director

Gilla Kaplan

68 1998 Independent Director

James Loughlin

72 2007 Independent Director

Ernest Mario

76 2007 Independent Director